Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Date	Type	Amount	Amount (Split Adj)	Record Date	Pay Date
Mar 14, 2024	Cash	CHF 9.6	CHF 9.6	Mar 15, 2024	Mar 18, 2024
Mar 16, 2023	Cash	CHF 9.5	CHF 9.5	Mar 17, 2023	Mar 20, 2023
Mar 17, 2022	Cash	CHF 9.3	CHF 9.3	Mar 18, 2022	Mar 21, 2022
Mar 18, 2021	Cash	CHF 9.1	CHF 9.1	Mar 19, 2021	Mar 22, 2021
Mar 19, 2020	Cash	CHF 9	CHF 9	Mar 20, 2020	Mar 23, 2020
Mar 07, 2019	Cash	CHF 8.7	CHF 8.7	Mar 08, 2019	Mar 11, 2019
Mar 15, 2018	Cash	CHF 8.3	CHF 8.3	Mar 16, 2018	Mar 19, 2018
Mar 16, 2017	Cash	CHF 8.2	CHF 8.2	Mar 17, 2017	Mar 20, 2017
Mar 03, 2016	Cash	CHF 8.1	CHF 8.1	Mar 04, 2016	Mar 07, 2016
Mar 05, 2015	Cash	CHF 8	CHF 8	Mar 06, 2015	Mar 10, 2015
Mar 06, 2014	Cash	CHF 7.8	CHF 7.8	Mar 10, 2014	Mar 11, 2014
Mar 07, 2013	Cash	CHF 7.35	CHF 7.35	Mar 11, 2013	Mar 12, 2013
Mar 08, 2012	Cash	CHF 6.8	CHF 6.8	Mar 12, 2012	Mar 13, 2012
Mar 03, 2011	Cash	CHF 6.6	CHF 6.6	Mar 07, 2011	Mar 08, 2011
Mar 04, 2010	Cash	CHF 6	CHF 6	Mar 08, 2010	Mar 09, 2010

Roche Holding AG

Dividends

Splits